Conversation with The Cancer LetterCOVID-19 & CancerFree As Italy’s COVID-19 incidence curve flattens, Curigliano sees lessons for the U.S. April 03, 2020Vol.46 No.14By Alexandria Carolan
Conversation with The Cancer LetterFree A COVID-19 update from New York: “The only thing I hear at night now is the wail of ambulances” April 03, 2020Vol.46 No.14By Matthew Bin Han Ong
FreeGuest Editorial What cancer immunologists are doing about COVID-19 April 03, 2020Vol.46 No.14By Rachel Humphrey
COVID-19 & CancerFreeGuest Editorial Friending viral foes: The Zika story and (perhaps) lessons for COVID-19 April 03, 2020Vol.46 No.14By Scott M. Lippman
COVID-19 & CancerFreeTrials & Tribulations Against all oddsUnrelated stem cell transplants in coronavirus times March 27, 2020Vol.46 No.13By Steven Devine and Alexander Schmidt
Conversation with The Cancer LetterCOVID-19 & CancerFree Curigliano: Italy’s COVID-19 cases keep rising; maybe next week the curve will flatten6,205 health professionals have tested positive and 44 have died March 27, 2020Vol.46 No.13By Alexandria Carolan
Conversation with The Cancer LetterCOVID-19 & CancerFree Knudsen, Flomenberg: Eliminate digital health disparities; we don’t want telemedicine to be for the one-percenters March 27, 2020Vol.46 No.13By Matthew Bin Han Ong
Conversation with The Cancer LetterCOVID-19 & CancerFree Hollander: Fix telehealth infrastructure—or America will be just as unprepared for the next pandemic March 27, 2020Vol.46 No.13By Matthew Bin Han Ong
COVID-19 & CancerFree Class of drugs used to treat CAR T-cell toxicity may reduce COVID-19 deathsTwo randomized trials announced March 24, 2020Vol.46 No.13By Paul Goldberg
